Financing Round

© monsitj / Getty Images

Vial secures $67m in funding for biotech-focused CRO

By Ben Hargreaves

The CRO focuses its services towards biotechs by stating that they are cheaper and more efficient compared to rivals, and it was this principle that drew in General Catalyst to provide investment.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All